FLGR-242 (Follistatin)
An experimental follistatin-based research peptide investigated for its potential to inhibit myostatin, one of the body’s natural brakes on muscle growth.
What It Is
FLGR-242 is an experimental follistatin-based research peptide of interest because of its potential to influence the myostatin/activin pathway — one of the body’s primary regulatory systems for skeletal muscle growth. Myostatin (GDF-8) is a negative regulator of muscle mass, signaling through activin type II receptors to limit growth.
Follistatin works upstream by binding myostatin and other TGF-β superfamily members, helping prevent them from interacting with their receptors. The proposed research logic is: less myostatin signaling → less inhibition of muscle growth → more potential for hypertrophy. Follistatin isn’t selective only for myostatin, though — it also interacts with activins and other TGF-β ligands, which is why this pathway needs to be approached with more nuance than “a muscle-building peptide.”
Who May Benefit
- Muscle growth and hypertrophy research
- Preserving lean tissue during caloric restriction
- Recovery from periods of muscle loss
- Strength and performance research
- Myostatin/activin pathway research
- Long-term muscle preservation and healthy-aging research
What to Expect
Preclinical follistatin research has produced substantial muscle-mass increases in animal models, but translating those findings directly to humans is not established, and prior attempts to therapeutically target this pathway have shown mixed clinical results.
FLGR-242 specifically is a modified follistatin construct designed to alter circulation, binding, or biological activity relative to natural follistatin — it should not be assumed to behave identically to unmodified follistatin.
What to Pair It With
Reconstitution
Specific reconstitution figures for this compound weren’t included in the source material. Reconstitution ratios vary by vial size and intended concentration — use a peptide reconstitution calculator and consult your research protocol source before proceeding.
Suggested Research Dosing Strategy
Administration Notes
Reconstitute with 1 mL bacteriostatic water per the source protocol, adjusting for the actual labeled amount in the vial rather than assuming a standard concentration.
Because different FLGR-242 products may have different concentrations and formulations, always verify the vial’s actual amount before calculating dosing.
Research Considerations
Most anabolic research strategies focus on turning growth signals up; follistatin research instead looks at removing some of the body’s natural brakes on muscle growth — a fundamentally different mechanism.
The underlying follistatin/myostatin biology is legitimate and well studied preclinically, but FLGR-242 itself remains an experimental research compound, and human data are not yet at a point where it could be considered clinically established.
Have a specific question about FLGR-242 (Follistatin)? Chat with Pulse, Signal IQ’s free AI research assistant — ask about mechanisms, stacking, or how it compares to other compounds.